Latest Ally Bridge Group (NY) LLC Stock Portfolio
Ally Bridge Group (NY) LLC Performance:
2025 Q3: 9.07%YTD: 9.88%2024: 6.83%
Performance for 2025 Q3 is 9.07%, and YTD is 9.88%, and 2024 is 6.83%.
About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings
Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $164.2 Millions as of 30 Sep, 2025.
The top stock holdings of Ally Bridge Group (NY) LLC are SLNO, MDGL, ATAI. The fund has invested 12.4% of it's portfolio in SOLENO THERAPEUTICS INC and 9.1% of portfolio in MADRIGAL PHARMACEUTICALS INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), MERUS N V (MRUS) and ENLIVEN THERAPEUTICS INC stocks. They significantly reduced their stock positions in MIND MEDICINE MINDMED INC (MNMD), LENZ THERAPEUTICS INC and TARSUS PHARMACEUTICALS INC (TARS). Ally Bridge Group (NY) LLC opened new stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL), ATAI BECKLEY NV (ATAI) and ASCENDIS PHARMA A/S - ADR. The fund showed a lot of confidence in some stocks as they added substantially to PROMIS NEUROSCIENCES INC (PMN), MONOPAR THERAPEUTICS INC (MNPR) and SOLENO THERAPEUTICS INC (SLNO).
The top stock holdings of Ally Bridge Group (NY) LLC are SLNO, MDGL, ATAI. The fund has invested 12.4% of it's portfolio in SOLENO THERAPEUTICS INC and 9.1% of portfolio in MADRIGAL PHARMACEUTICALS INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), MERUS N V (MRUS) and ENLIVEN THERAPEUTICS INC stocks. They significantly reduced their stock positions in MIND MEDICINE MINDMED INC (MNMD), LENZ THERAPEUTICS INC and TARSUS PHARMACEUTICALS INC (TARS). Ally Bridge Group (NY) LLC opened new stock positions in MADRIGAL PHARMACEUTICALS INC (MDGL), ATAI BECKLEY NV (ATAI) and ASCENDIS PHARMA A/S - ADR. The fund showed a lot of confidence in some stocks as they added substantially to PROMIS NEUROSCIENCES INC (PMN), MONOPAR THERAPEUTICS INC (MNPR) and SOLENO THERAPEUTICS INC (SLNO).
Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ally Bridge Group (NY) LLC made a return of 9.07% in the last quarter. In trailing 12 months, it's portfolio return was 7.27%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| madrigal pharmaceuticals inc | 14,980,800 |
| atai beckley nv | 12,098,300 |
| ascendis pharma a/s - adr | 10,155,200 |
| taysha gene therapies inc | 6,206,830 |
| amylyx pharmaceuticals inc | 5,944,140 |
| eupraxia pharmaceuticals inc | 5,398,500 |
| arcutis biotherapeutics inc | 4,396,200 |
| avalo therapeutics inc | 2,263,650 |
New stocks bought by Ally Bridge Group (NY) LLC
Additions
| Ticker | % Inc. |
|---|---|
| promis neurosciences inc | 367 |
| monopar therapeutics inc | 86.63 |
| soleno therapeutics inc | 69.16 |
Additions to existing portfolio by Ally Bridge Group (NY) LLC
Reductions
| Ticker | % Reduced |
|---|---|
| mind medicine mindmed inc | -50.23 |
| lenz therapeutics inc | -48.92 |
| tarsus pharmaceuticals inc | -41.59 |
| compass pathways plc | -30.88 |
| solid biosciences inc | -24.15 |
| tectonic therapeutic inc | -15.33 |
Ally Bridge Group (NY) LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| geron corp | -4,584,580 |
| lexeo therapeutics inc | -3,486,550 |
| oric pharmaceuticals inc | -4,929,130 |
| centessa pharmaceuticals plc | -3,862,980 |
| enliven therapeutics inc | -5,644,760 |
| verona pharma plc | -15,199,100 |
| korro bio inc | -1,926,240 |
| merus n v | -7,374,940 |
Ally Bridge Group (NY) LLC got rid off the above stocks
Sector Distribution
Ally Bridge Group (NY) LLC has about 78.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 78.3 |
| Others | 21.7 |
Market Cap. Distribution
Ally Bridge Group (NY) LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
- MID-CAP
- NANO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 40.8 |
| UNALLOCATED | 21.7 |
| MICRO-CAP | 15.1 |
| MID-CAP | 12.5 |
| NANO-CAP | 9.8 |
Stocks belong to which Index?
About 26% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 74 |
| RUSSELL 2000 | 26 |
Ally Bridge Group (NY) LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC has 18 stocks in it's portfolio. About 57.6% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | whitehawk therapeutics inc | 0.95 | 817,939 | 1,554,080 | unchanged | 0.00 | ||
| AMLX | amylyx pharmaceuticals inc | 3.62 | 437,391 | 5,944,140 | new | |||
| ARQT | arcutis biotherapeutics inc | 2.68 | 233,220 | 4,396,200 | new | |||
| ATAI | atai beckley nv | 7.37 | 2,287,000 | 12,098,300 | new | |||
| AVTX | avalo therapeutics inc | 1.38 | 178,100 | 2,263,650 | new | |||
| CMPS | compass pathways plc | 3.58 | 1,026,380 | 5,881,170 | reduced | -30.88 | ||
| CNTA | centessa pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GERN | geron corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MDGL | madrigal pharmaceuticals inc | 9.12 | 32,662 | 14,980,800 | new | |||
| MNMD | mind medicine mindmed inc | 2.60 | 361,444 | 4,261,420 | reduced | -50.23 | ||
| MNPR | monopar therapeutics inc | 3.21 | 64,455 | 5,264,040 | added | 86.63 | ||
| MRUS | merus n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ORIC | oric pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PMN | promis neurosciences inc | 1.61 | 6,233,500 | 2,649,240 | added | 367 | ||
| RNA | avidity biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SLDB | solid biosciences inc | 2.06 | 549,182 | 3,388,450 | reduced | -24.15 | ||
| SLNO | soleno therapeutics inc | 12.45 | 302,483 | 20,447,900 | added | 69.16 | ||
| TARS | tarsus pharmaceuticals inc | 2.56 | 70,778 | 4,206,340 | reduced | -41.59 | ||
| TSHA | taysha gene therapies inc | 3.78 | 1,898,110 | 6,206,830 | new | |||